Literature DB >> 16375641

Fertility-sparing therapy for young women with endometrial cancer.

Michael Frumovitz1, David M Gershenson.   

Abstract

Approximately 1600 women under the age of 40 will be diagnosed with endometrial cancer this year. For these women, preservation of fertility may be one of the most important factors when seeking treatment options. The objective of this article is to review the available literature on fertility-sparing therapy for young women with endometrial cancer. Patient selection, pretreatment testing, treatment regimens, response rates and pregnancy outcomes will be explored. Recommendations regarding this approach for the treatment of endometrial cancer in young women will also be made.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16375641     DOI: 10.1586/14737140.6.1.27

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  4 in total

Review 1.  Personalized care in uterine cancer.

Authors:  David A Iglesias; Diane C Bodurka
Journal:  Clin Adv Hematol Oncol       Date:  2012-12

2.  Application of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer Bojana Djordjevic, Shannon Westin, Russell R. Broaddus.

Authors:  Bojana Djordjevic; Shannon Westin; Russell R Broaddus
Journal:  Surg Pathol Clin       Date:  2012-12-01

3.  Fertility Sparing Treatment in Patients With Early Stage Endometrial Cancer, Using a Combination of Surgery and GnRH Agonist: A Monocentric Retrospective Study and Review of the Literature.

Authors:  Stéphanie Tock; Pascale Jadoul; Jean-Luc Squifflet; Etienne Marbaix; Jean-François Baurain; Mathieu Luyckx
Journal:  Front Med (Lausanne)       Date:  2018-08-27

Review 4.  Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification.

Authors:  Anna Franca Cavaliere; Federica Perelli; Simona Zaami; Marco D'Indinosante; Irene Turrini; Marco Giusti; Giuseppe Gullo; Giuseppe Vizzielli; Alberto Mattei; Giovanni Scambia; Annalisa Vidiri; Fabrizio Signore
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.